Tobise K, Ishikawa Y, Holmer S R, Im M J, Newell J B, Yoshie H, Fujita M, Susannie E E, Homcy C J
Department of Medicine I, Asahikawa Medical College, Japan.
Circ Res. 1994 Apr;74(4):596-603. doi: 10.1161/01.res.74.4.596.
We investigated the developmental regulation of the beta-adrenergic receptor-Gs-adenylyl cyclase pathway in myocardial membranes from fetal, neonatal, adult, and mature adult rats by measuring the density of the beta-adrenergic receptor and the activities of the stimulatory guanine nucleotide-binding protein Gs and the adenylyl cyclase enzyme. Total beta-adrenergic receptor content (in femtomoles per milligram protein) was greatest in the fetal (124.4 +/- 20.5 fmol/mg) and neonatal (122.3 +/- 16.1 fmol/mg) stages and gradually decreased in the adult (90.9 +/- 8.0 fmol/mg) and mature adult (70.0 +/- 9.6 fmol/mg) stages. An equivalent pattern was seen for adenylyl cyclase activity: the basal activity of the effector enzyme or that measured in the presence of 0.1 mmol/L isoproterenol with 0.1 mmol/L Gpp(NH)p, 10 mmol/L NaF, or 0.05 mmol/L forskolin was greater in the fetus and the neonate than in the adult and the mature adult. These data suggested that decreased stimulation of the catalytic unit by Gs could be the underlying cause of diminished adenylyl cyclase activity with aging. However, quantification of Gs by reconstitution into S49 cyc- membranes (in picomoles cAMP per microgram for 10 minutes) demonstrated no significant decrease during development from fetus (1.55 +/- 0.1 pmol/microgram) to neonate (1.9 +/- 0.5 pmol/microgram) and subsequent aging to adult (2.6 +/- 0.2 pmol/micrograms) and mature adult (1.9 +/- 0.2 pmol/microgram). When Northern blot analysis was used to characterize the relative amounts of mRNA coding for Gs alpha, no significant differences were seen among the developmental stages studied.(ABSTRACT TRUNCATED AT 250 WORDS)
我们通过测量β-肾上腺素能受体的密度、刺激性鸟嘌呤核苷酸结合蛋白Gs和腺苷酸环化酶的活性,研究了胎儿、新生儿、成年和成熟成年大鼠心肌膜中β-肾上腺素能受体-Gs-腺苷酸环化酶途径的发育调控。总β-肾上腺素能受体含量(每毫克蛋白质中的飞摩尔数)在胎儿期(124.4±20.5 fmol/mg)和新生儿期(122.3±16.1 fmol/mg)最高,在成年期(90.9±8.0 fmol/mg)和成熟成年期(70.0±9.6 fmol/mg)逐渐降低。腺苷酸环化酶活性呈现类似模式:效应酶的基础活性或在存在0.1 mmol/L异丙肾上腺素与0.1 mmol/L Gpp(NH)p、10 mmol/L NaF或0.05 mmol/L福斯可林的情况下测得的活性,在胎儿和新生儿中高于成年和成熟成年个体。这些数据表明,随着年龄增长,Gs对催化单位的刺激减少可能是腺苷酸环化酶活性降低的根本原因。然而,通过重组到S49 cyc-膜中对Gs进行定量(每微克10分钟产生的皮摩尔cAMP)显示,从胎儿(1.55±0.1 pmol/微克)发育到新生儿(1.9±0.5 pmol/微克),随后衰老到成年(2.6±0.2 pmol/微克)和成熟成年(1.9±0.2 pmol/微克)期间,Gs没有显著下降。当使用Northern印迹分析来表征编码Gsα的mRNA的相对量时,在所研究的发育阶段之间未观察到显著差异。(摘要截断于250字)